source
- Rare disease reform, CMC risk, reshoring US trials top of mind ahead of PDUFA VIII meetingThe FDA gathers Wednesday to hear what industry stakeholders and the public want included in the latest iteration of the Prescription Drug User Fee Act that sets the agency’s priorities for fiscal…
- HHS nominee Chris Klomp faces questioning from Sen. Elizabeth Warren on voluntary drug‑pricing contractsDeputy Secretary of Health and Human Services nominee Chris Klomp testified before the Senate Finance Committee on September 15, 2026. The hearing was described as relatively mild overall. During…